<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778943</url>
  </required_header>
  <id_info>
    <org_study_id>TDGKJZ</org_study_id>
    <nct_id>NCT04778943</nct_id>
  </id_info>
  <brief_title>Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion</brief_title>
  <official_title>Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will retrospectively study lumbar spinal stenosis patients who underwent&#xD;
      OLIF or MIS-TLIF with percutaneous pedicle screw fixation between January 2016 and December&#xD;
      2019.The investigators will measure estimated blood loss, operative time, hospital stay,&#xD;
      cost, reoperation, and complication incidence, visual analogue scale (VAS), Oswestry&#xD;
      Disability Index (ODI), Japanese Orthopaedic Association (JOA), and Short Form-36 (SF-36)&#xD;
      scores, discal and foraminal height, lumbar lordotic angle, and fusion status.The&#xD;
      investigators will conduct to evaluate postoperative improvements, complications, and&#xD;
      reoperation rates between patients with lumbar spinal stenosis (LSS) undergoing oblique&#xD;
      lateral interbody fusion (OLIF) or minimally invasive transforaminal lumbar interbody fusion&#xD;
      (MIS-TLIF).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 28, 2021</start_date>
  <completion_date type="Anticipated">March 29, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oswestry Disability Index (ODI), , and Short Form-36 (SF-36) scores; discal and foraminal height; lumbar lordotic angle; and fusion status.</measure>
    <time_frame>2 Years</time_frame>
    <description>Before surgery and at the last follow-up, the following information was recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Japanese Orthopaedic Association (JOA)</measure>
    <time_frame>2 Years</time_frame>
    <description>Before surgery and at the last follow-up, the following information was recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS)</measure>
    <time_frame>2 Years</time_frame>
    <description>Before surgery and at the last follow-up, the following information was recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form-36 (SF-36) scores</measure>
    <time_frame>2 Years</time_frame>
    <description>Before surgery and at the last follow-up, the following information was recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Complication rate</measure>
    <time_frame>2 Years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Lumbar Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>oblique lateral interbody fusion (OLIF)</arm_group_label>
    <description>Patients with lumbar spinal stenosis undergoing oblique lateral interbody fusion (OLIF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)</arm_group_label>
    <description>Patients with lumbar spinal stenosis undergoing minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surgery(OLIF and MIS-TLIF)</intervention_name>
    <description>oblique lateral interbody fusion (OLIF); minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)</description>
    <arm_group_label>minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)</arm_group_label>
    <arm_group_label>oblique lateral interbody fusion (OLIF)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were diagnosed with LSS and underwent either MIS-TLIF or OLIF surgery between&#xD;
        January 2016 and December 2019.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  LSS due to neurogenic claudication; Central stenosis or lateral stenosis who need&#xD;
             surgery; Single-level, low-grade (Meyerding grade 1 or 2) isthmic spondylolisthesis or&#xD;
             degenerative spondylolisthesis; and imaging findings consistent with the symptoms of&#xD;
             LSS.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  trauma, active infection, malignant tumors, spinal deformity, previous lumbar fusion,&#xD;
             multi-segment fusion, multi-level, high-grade (Meyerding grade 3 or 4) isthmic&#xD;
             spondylolisthesis or degenerative spondylolisthesis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 28, 2021</last_update_submitted>
  <last_update_submitted_qc>February 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tang-Du Hospital</investigator_affiliation>
    <investigator_full_name>Fei-Long Wei</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Lumbar spinal stenosis</keyword>
  <keyword>OLIF</keyword>
  <keyword>MIS-TLIF</keyword>
  <keyword>postoperative improvements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

